Effect of population-wide screening for presymptomatic early-stage type 1 diabetes on paediatric clinical care [0.03%]
人群范围内筛查无症状的1期糖尿病对儿科临床护理的影响
Ezio Bonifacio,Christiane Winkler,Peter Achenbach et al.
Ezio Bonifacio et al.
Sex, race, and BMI in clinical trials of medications for obesity over the past three decades: a systematic review [0.03%]
过去三十年肥胖症药物临床试验中的性别、种族和体重指数的身体质量指数系统评价
Moath S Alsaqaaby,Sarah Cooney,Carel W le Roux et al.
Moath S Alsaqaaby et al.
Medications for obesity have been studied in various populations over the past three decades. We aimed to quantify the baseline demographic characteristics of BMI, sex, age, and race in randomised clinical trials (RCTs) across three decades...
Use of melatonin supplements and risk of type 2 diabetes and cardiovascular diseases in the USA: insights from three prospective cohort studies [0.03%]
褪黑素补充剂在美国的使用及其与二型糖尿病和心血管疾病风险之间的关系：来自三项前瞻性队列研究的新证据
Yanping Li,Tianyi Huang,Susan Redline et al.
Yanping Li et al.
Background: Use of melatonin supplements has been increasing substantially in both children and adults in the USA; however, their long-term cardiometabolic effects remain unclear. We aimed to assess the associations betwe...
Pei Xue,Diana A Nôga,Christian Benedict
Pei Xue
Setmelanotide for the treatment of acquired hypothalamic obesity: a phase 2, open-label, multicentre trial [0.03%]
塞美拉尼肽治疗获得性下丘脑肥胖症二期开放多中心试验
Christian L Roth,Cecilia Scimia,Ashley H Shoemaker et al.
Christian L Roth et al.
Background: Hypothalamic obesity resulting from hypothalamic damage might affect melanocortin signalling. We investigated the melanocortin-4 receptor agonist setmelanotide for treatment of hypothalamic obesity. ...
Manuel Tena-Sempere
Manuel Tena-Sempere
Comparing advanced hybrid closed loop therapy and standard insulin therapy in pregnant women with type 1 diabetes (CRISTAL): a parallel-group, open-label, randomised controlled trial [0.03%]
comparisong先进混合闭环疗法与标准胰岛素治疗在1型糖尿病孕妇中的疗效：平行分组、开放标签、随机对照试验（CRISTAL）
Katrien Benhalima,Kaat Beunen,Nancy Van Wilder et al.
Katrien Benhalima et al.
Background: Advanced hybrid closed loop (AHCL) therapy can improve glycaemic control in pregnant women with type 1 diabetes. However, data are needed on the efficacy and safety of AHCL systems as these systems, such as th...
Randomized Controlled Trial
The lancet. Diabetes & endocrinology. 2024 Jun;12(6):390-403. DOI:10.1016/S2213-8587(24)00089-5 2024
Demarcating the benefits of hybrid closed loop therapy in pregnant women with type 1 diabetes [0.03%]
妊娠期1型糖尿病患者混合闭环治疗的优势划分
Helen R Murphy,Eleanor M Scott
Helen R Murphy